Back to MW MARSHALL WACE, LLP

ACADACAD
19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ACADIA PHARMACEUTICALS INC

Yes. Marshall Wace holds 1,764,838 shares of ACAD (Acadia Pharmaceuticals), worth $44.7M, as of its Q2 2026 13F filing. It increased the position from 76,187 shares in Q1 2026. Marshall Wace has held ACAD since Q1 2024, across 10 quarterly 13F filings.

Current Value

$44.7M

Current Shares

1.8M

Total Value Change

+$34.9M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+2216.5%
$44.7M0.0%$25.30
47
2026-Q1
Decreased
76,187
-84.6%
$1.7M0.0%$22.26
0
2025-Q4
Decreased
493,379
-79.1%
$13.2M0.0%$26.71
0
2025-Q3
Increased
2.4M
+19.8%
$50.3M0.1%$21.34
35
2025-Q2
Increased
2M
+496.2%
$42.5M0.0%$21.57
47
2025-Q1
Decreased
330,396
-66.8%
$5.5M0.0%$16.61
0
2024-Q4
Decreased
993,593
-16.4%
$18.2M0.0%$18.35
0
2024-Q3
Decreased
1.2M
-57.2%
$18.3M0.0%$15.38
0
2024-Q2
Increased
2.8M
+431.1%
$45.1M0.1%$16.25
47
2024-Q1
New
522,413
-
$9.7M0.0%$18.49
38
2023-Q4
Exited
0
-100.0%
$00.0%$31.31
0
2023-Q3
Increased
941,755
+3689.4%
$19.6M0.0%$20.84
46
2023-Q2
New
24,852
-
$595,2060.0%$23.95
34
2022-Q2
Exited
0
-100.0%
$00.0%$14.09
0
2022-Q1
New
532,557
-
$12.9M0.0%$24.22
39
2021-Q1
Exited
0
-100.0%
$00.0%$25.80
0
2020-Q4
Decreased
848,679
-25.1%
$45.4M0.2%$53.46
0
2020-Q3
Increased
1.1M
+466.6%
$46.8M0.3%$41.25
56
2020-Q2
New
200,126
-
$9.7M0.1%$48.47
38

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used